Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy-Reference-Cited by-同舟云学术

Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy

Published:2024-05-31 Issue: Volume: Page:
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Friman Ola¹²^ORCID,Soltani Navid¹²,Lind Marcus³⁴⁵,Zetterqvist Pia²,Balintescu Anca⁶,Perner Anders⁷⁸,Oldner Anders¹²,Rooyackers Olav²⁹,Mårtensson Johan¹²^ORCID

Affiliation:

1. Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden.

2. Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.

3. Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.

4. Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.

5. Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

6. Department of Clinical Science and Education, Section of Anaesthesia and Intensive Care, South General Hospital, Karolinska Institutet, Stockholm, Sweden.

7. Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Denmark.

8. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

9. Division for Anesthesiology and Intensive Care, Department of Clinical Interventions and Technology CLINTEC, Karolinska Institutet Stockholm, Sweden.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2024.0035

Reference25 articles.

1. Glycemic lability index and mortality in critically ill patients—A multicenter cohort study

2. Hypoglycemia and Risk of Death in Critically Ill Patients

3. Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024

4. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic